Month: February 2021

BARTLETT, Tenn., Feb. 22, 2021 (GLOBE NEWSWIRE) — SurgePays, Inc. (OTCQB: SURG) (“SurgePays” or the “Company”), a fintech company building a next generation supply chain network that can offer wholesale goods and financial services for the underbanked more cost efficiently than traditional distribution models, announces today that Jjkareem (Jay) Jones, a telecom and software development executive with over 30 years of experience, has joined the Company’s Board of Directors.“Jay brings a wealth of hands-on and executive experience in the telecom industry that will be a tremendous asset to us as we aggressively roll out our nationwide wireless LocoRabbit services through the thousands of convenience stores and mini-marts that are the epicenters of the underbanked communities,” said SurgePays CEO and Chairman Brian Cox. “With both...

LOS ANGELES, Feb. 22, 2021 (GLOBE NEWSWIRE) — PLBY Group, Inc. (NASDAQ: PLBY) (the “Company”), a leading pleasure and leisure lifestyle company and owner of Playboy, one of the most recognizable and iconic brands in the world, today announced the appointment of Kevin Diamond to newly created role of Chief Digital Officer, reporting directly to Ben Kohn, Chief Executive Officer. In his new role, which begins on February 24, 2021, Mr. Diamond will be responsible for expanding PLBY Group’s global digital commerce business, elevating the Company’s global digital experience, and strengthening its technology infrastructure underpinning.Mr. Diamond joins PLBY Group from Forever 21, where he served as the Head of Global E-Commerce, responsible for the company’s more than $700 million global digital commerce business, its product and technology...

Bestyrelsen i Investeringsforeningen Jyske Invest har oprettet fusionsplan og redegørelse for skattefri fusion af følgende afdelinger i Investeringsforeningen Jyske Invest (CVR-nr. 24 26 05 26):Jyske Invest Favorit Obligationer KL (SE-nummer 12258623)fusioneres med Jyske Invest Højt Ratede Virksomhedsobligationer KL (SE-nummer 31006376) som den fortsættende afdelingJyske Invest Danske Aktier KL (SE-nummer 12258763)Jyske Invest Europæiske Aktier KL (SE-nummer 12258852)Jyske Invest Globale Aktier KL (SE-nummer 12258860)Jyske Invest Globale Aktier SRI KL (SE-nummer 31025761)Jyske Invest USA Aktier KL (SE-nummer 12259123)Jyske Invest Favorit Aktier KL (SE-nummer 12259263)fusioneres med Jyske Invest Bæredygtige Aktier KL (SE-nummer 41736607) som den fortsættende afdeling.Fusionen er betinget af, at den vedtages på ordinær generalforsamling i...

Build Out of Myford Facility Will Expand Current Footprint to Include Second Manufacturing Train with Both Upstream and Downstream Processing SuitesPhase 2 Has Potential to Increase Annual Revenue Generating Capacity by an Additional $100 MillionTUSTIN, Calif., Feb. 22, 2021 (GLOBE NEWSWIRE) — Avid Bioservices, Inc. (NASDAQ:CDMO) (NASDAQ:CDMOP), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient lives by providing high quality development and manufacturing services to biotechnology and pharmaceutical companies, today announced the initiation of Phase 2 of the company’s two-phase effort to expand the overall manufacturing capacity within its Myford facility. Work is now underway to further build out the company’s Myford facility to include a second manufacturing train with...

TORONTO, Feb. 22, 2021 (GLOBE NEWSWIRE) — Hudbay Minerals Inc. (“Hudbay” or the “company”) (TSX, NYSE:HBM) today announced that it is offering US$600 million aggregate principal amount of senior notes (the “New Notes”). The interest rate and other terms of the New Notes will be determined at pricing and are dependent upon market conditions and other factors.Hudbay plans to use the net proceeds from the offering of the New Notes to refinance all of its outstanding US$600 million aggregate principal amount of 7.625% senior notes due 2025 (the “Existing Notes”).The redemption of the Existing Notes is conditioned upon the successful closing of the offering of the New Notes, contemporaneous with or prior to the redemption date, and certain other terms and conditions set forth in the company’s redemption notice.The New Notes will not...

– Company eliminates $5.76 million of debt–Well-positioned to access near-term growth opportunities and acquisitions to enhance offering of full turn-key indoor controlled environment agriculture solutionsLAFAYETTE, Colo., Feb. 22, 2021 (GLOBE NEWSWIRE) — urban-gro, Inc. (NASDAQ: UGRO) (“urban-gro” or the “Company”), a leading global horticulture company that engineers and designs commercial Controlled Environment Agriculture (“CEA”) facilities and integrates complex environmental equipment systems into these high-performance facilities, today announced it has extinguished more than 80% of its indebtedness through repayment of $5.76 million in debt. Following this payment, the Company’s total debt is approximately $1.0 million.“urban-gro has made significant progress since the start of 2021. With the completion of our recent financing...

CAMBRIDGE, Mass., Feb. 22, 2021 (GLOBE NEWSWIRE) — Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, today announced that Sam Agresta, M.D., M.P.H, Chief Medical officer is scheduled to participate in a Leukemias panel discussion at the Cowen 41st Annual Healthcare Conference at 11:40 a.m. ET on March 3, 2021.About Foghorn TherapeuticsFoghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory...

Catalyst Supporting Facebook Live Panel on Living with a Rare Disease Hosted by The MightyCatalyst Kicks off Rare Reason CampaignCORAL GABLES, Fla., Feb. 22, 2021 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating, chronic neuromuscular and neurological diseases, today announced its support for Rare Disease Day 2021.Rare Disease Day, observed on February 28th this year, involves activities worldwide to raise awareness of rare diseases and their impact on patients’ lives among the general public and decision-makers in industry and government. Efforts taken on this day (and throughout the year) are hoped to increase funds, research, resources, and treatments for the...